I-CORT Trademark

Trademark Overview


On Monday, June 19, 2006, a trademark application was filed for I-CORT with the United States Patent and Trademark Office. The USPTO has given the I-CORT trademark a serial number of 78911366. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 17, 2011. This trademark is owned by Breath Limited. The I-CORT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system including asthma, chronic obstructive pulmonary disease (COPD), breathlessness, cystic fibrosis, pulmonary hypertension and other respiratory diseases and treatment preparations therefor that can be administered to a patient through absorption through the lung; pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholest...
i-cort

General Information


Serial Number78911366
Word MarkI-CORT
Filing DateMonday, June 19, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 17, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2007

Trademark Statements


Goods and ServicesPharmaceutical and medicinal preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system including asthma, chronic obstructive pulmonary disease (COPD), breathlessness, cystic fibrosis, pulmonary hypertension and other respiratory diseases and treatment preparations therefor that can be administered to a patient through absorption through the lung; pharmaceutical preparations, namely, preparations for the prevention and treatment of cancers; pharmaceutical preparations, namely, platelet stimulating factors; pharmaceutical cardiovascular preparations; pharmaceutical preparations for the treatment of cardiovascular disease, urological disorders, gastrointestinal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, obesity and respiratory diseases, fungal disorders; pharmaceutical preparations, namely, anti-inflammatory analgesics; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, medicated tissue and skin repair preparations; pharmaceutical preparations for the treatment of diabetes, cancer; pharmaceutical preparations comprising protein kinase or phosphatase for use in the treatment of cancer and Parkinson's disease; pharmaceutical preparations affecting signal transduction pathways for use in the treatment of inflammatory diseases, autoimmune diseases, and psychiatric diseases; pharmaceutical preparations for the prevention and/or treatment of cancer, carcinomas and sarcomas; pharmaceutical preparations for the prevention and/or treatment of tumors of any description; pharmaceutical preparations for the treatment of pains, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; analgesics; frostbite salve for pharmaceutical purposes; hemorrhoid treatment preparations; pharmaceutical preparations for the treatment of headaches; bath salts for medical purposes; medicated mouthwashes; herbal mud packs for therapeutic purposes; tranquilizers; sedatives; tobacco free cigarettes for medical purposes; medicines for alleviating constipation; contraceptive preparations; radiological contrast substances for medical purposes, namely, contrast media for in-vivo imaging; corn remedies, namely, corn creams, corn pads and corn plasters; cotton for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of pain, fever, angina, otorhinolaryngology, gastric and liver illnesses, heart illnesses, arterial and venous illnesses, rheumatic illnesses; mineral water for medical purposes; pharmaceutical preparations for the treatment of tremors, smooth muscle disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone; pharmaceutical preparations for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical preparations for the treatment of muscle dystonias, nerve disorders, spasmodic striated, smooth or cardiac muscles; pharmaceutical preparations for the treatment of cerebral palsy; pharmaceutical preparations and substances, namely anti-infective, anti-bacterials, antibiotics, antivirals, antidiabetic preparations, cardiovascular preparations, hemostatic agents; pharmaceutical preparations and substances for the treatment of cancer, HIV, obesity and respiratory and urologic disorders and diseases; pharmaceutical preparations and substances for the treatment of acute ischemic stroke and traumatic brain injury (TBI); cerebral vasodilators; prescription pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, peripheral nervous system, cardiovascular system, gastro-intestinal system; prescription pharmaceutical preparations and substances for use in pain control; anesthetics for surgical and non-surgical use; pharmaceutical preparations for use in oncology for the prevention and treatment of disorders; prescription pharmaceutical preparations and substances for the treatment and prevention of diabetes; vaccines; dietetic substances adapted for medical purposes; nebules for inhalation, namely liquid drug formulations designed for delivery to the patient via a nebuliser for administration to the lung

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 26, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBreath Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon N12 9RT
GB

Party NameBreath Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBiggin Hill TN16 3TR
GB

Trademark Events


Event DateEvent Description
Tuesday, January 18, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 17, 2011ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2010EXTENSION 5 GRANTED
Thursday, June 17, 2010EXTENSION 5 FILED
Thursday, June 17, 2010TEAS EXTENSION RECEIVED
Thursday, June 17, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 17, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 3, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 1, 2010PAPER RECEIVED
Tuesday, December 22, 2009EXTENSION 4 GRANTED
Tuesday, December 15, 2009EXTENSION 4 FILED
Tuesday, December 15, 2009TEAS EXTENSION RECEIVED
Wednesday, June 17, 2009EXTENSION 3 GRANTED
Thursday, May 28, 2009EXTENSION 3 FILED
Wednesday, June 17, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 28, 2009TEAS EXTENSION RECEIVED
Thursday, November 20, 2008EXTENSION 2 GRANTED
Thursday, November 20, 2008EXTENSION 2 FILED
Thursday, November 20, 2008TEAS EXTENSION RECEIVED
Tuesday, June 17, 2008EXTENSION 1 GRANTED
Tuesday, June 17, 2008EXTENSION 1 FILED
Tuesday, June 17, 2008TEAS EXTENSION RECEIVED
Tuesday, December 18, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 25, 2007PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2007NOTICE OF PUBLICATION
Tuesday, August 21, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 21, 2007ASSIGNED TO LIE
Saturday, July 7, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 6, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 6, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 6, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 6, 2007FINAL REFUSAL E-MAILED
Friday, April 6, 2007FINAL REFUSAL WRITTEN
Wednesday, March 28, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 27, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 27, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 28, 2006NON-FINAL ACTION E-MAILED
Thursday, September 28, 2006NON-FINAL ACTION WRITTEN
Thursday, September 28, 2006ASSIGNED TO EXAMINER
Monday, June 26, 2006NEW APPLICATION ENTERED IN TRAM